Century Therapeutics CEO Lalo Flores steps down, shares fall
12/04/2023 15:15
** Shares of biotechnology firm Century Therapeutics Inc
IPSC.O fall ~5% to $3.00
** Company says Lalo Flores steps down as CEO, effective
April 11
** Greg Russotti, current chief technology officer,
appointed as interim CEO
** Stock down 4.6% so far in 2023
(Reporting by Anne Florentyna Gnanaraja Sekar in Bengaluru)
((AnneFlorentyna.GnanarajaSekar@thomsonreuters.com;))
Recent news on Century Therapeutics
See all newsCentury Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Century Therapeutics Q2 net loss misses estimates on lease termination loss
Brief: Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million
Century Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Century Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview